GSK press releases Follow Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD) Approval based on the positive MATINEE and METREX phase III trials https://www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-approved-by-us-fda/ gsk.com
